Jasper Therapeutics is trading at $0.66 (-5.39%) amid broad risk-off trading following renewed U.S.-Iran clashes.
- No new company-specific announcement or filing was identified for August 31, 2026.
- Rising oil prices and increased expectations for a September Federal Reserve rate hike pressured equities; Reuters reported lower U.S. futures.
- Biotech shares also weakened, reinforcing a sector-sensitive explanation.